Anika Therapeutics (ANIK) Operating Expenses (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Operating Expenses of $18.3 million for Q2 2026, down 1.36% year-over-year from $18.5 million in Q2 2025, and down 25.3% quarter-over-quarter from $24.5 million in Q1 2026.
Anika Therapeutics (ANIK) Operating Expenses (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Operating Expenses for 17 consecutive years, with $18.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses fell 1.36% year-over-year to $18.3 million; the TTM figure through Jun 2026 stood at $80.1 million (up 7.08% YoY), while the FY2025 annual figure was $74.9 million, down 7.7% from the prior year.
- Operating Expenses slipped to $18.3 million in Q2 2026 per ANIK's latest filing, from $24.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $35.4 million in Q1 2023 and bottomed at -$18.9 million in Q4 2023.
- Historically, Operating Expenses has averaged $19.4 million across 5 years, with a median of $20.5 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses plunged 146.33% — and 2024, when it jumped 194.2%.
- Anika Therapeutics' Operating Expenses stood at -$12.6 million in 2022, then tumbled by 49.9% to -$18.9 million in 2023, then soared by 194.2% to $17.8 million in 2024, then rose by 3.94% to $18.5 million in 2025, then dropped by 1.31% to $18.3 million in 2026.
- Business Quant data shows ANIK's Operating Expenses at $18.3 million in Q2 2026, $24.5 million in Q1 2026, and $18.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Anika Therapeutics | 288.59 Mn | 250.18 Mn | 21.24 Mn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.29 Mn |
| Mar 31, 2026 | 24.49 Mn |
| Dec 31, 2025 | 18.53 Mn |
| Sep 30, 2025 | 18.82 Mn |
| Jun 30, 2025 | 18.54 Mn |
| Mar 31, 2025 | 18.97 Mn |
| Dec 31, 2024 | 17.83 Mn |
| Sep 30, 2024 | 19.49 Mn |
| Jun 30, 2024 | 22.30 Mn |
| Mar 31, 2024 | 21.48 Mn |
| Dec 31, 2023 | -18.93 Mn |
| Sep 30, 2023 | 32.62 Mn |
| Jun 30, 2023 | 32.60 Mn |
| Mar 31, 2023 | 35.40 Mn |
| Dec 31, 2022 | -12.63 Mn |
| Sep 30, 2022 | 28.58 Mn |
| Jun 30, 2022 | 28.24 Mn |
| Mar 31, 2022 | 25.36 Mn |
| Dec 31, 2021 | 27.26 Mn |
| Sep 30, 2021 | 21.72 Mn |